Chromocell Therapeutics Corp's total assets for Q1 2025 were $911.18K, a decrease of -33.45% from the previous quarter. CHRO total liabilities were $5.11M for the fiscal quarter, a 25.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.